Major disease medical insurance drug auditing and drug treatment management system

Abstract

The invention relates to the technical field of medical data processing, in particular to a major disease medical insurance drug auditing and drug treatment management system which comprises a physician affirmation module, a pharmacist affirmation module, a medication planning module, a basic database, a physician end, a pharmacist end and a patient end. Through dual affirmation of physicians and drugs, the medical insurance drug auditing efficiency and precision are improved, and the medication risk of patients is reduced. The risk of medical negligence in drug treatment of the patients is reduced by adopting a patient medication safety evaluation module and a medication safety comprehensive evaluation module, and the reasonability of doctors' prescriptions and medical advice is improved.

Description

technical field [0001] The invention relates to the technical field of medical data processing, in particular to a critical disease medical insurance drug review and drug treatment management system. Background technique [0002] With the improvement of economic level and medical level, the country attaches great importance to high-value drugs for the treatment of major diseases and rare diseases. Since December 2016, Sichuan Province has reviewed 106 types of drugs, including tumor drugs, immune system drugs, and cardiovascular and cerebrovascular drugs. At present, the incidence of ADE in outpatient drug safety is about 33%, and many drugs need to review the admission standards and monitor the drug risks of patients, so pharmacists also need to participate in the review, monitor the drug safety of patients, and at the same time monitor and reduce medical insurance. Reasonable use, the current review process is mainly after the doctor completes the diagnosis of the disease...

AI Technical Summary

Problems solved by technology

[0003] However, there are currently the following problems in drug safety: 1. The amount of audits for patients using medical insurance drugs is gradually increasing, and the types of drug audits increase, which increases the burden of drug audits, easily leads to audit errors, and increases the risk of patients' medication; 2. Drug interaction mechanisms are ignored Patients may have a variety of diseases coexisting. With the use of drugs approved by the patient's medical insurance, the effectiveness will increase and the survival period will increase. However, the risk of drug interactions may increase. At the same time, the patient's living and eating habits are also ignored. , clinical test indicators, etc., further increasing the risk of drug use for patients

Images